Saturday 17 October 2026
Export ZCMD’s income statement to Excel — free account
Zhongchao Inc.
ZCMD Healthcare Health Information Services
Zhongchao Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.4 million, down 28.3% from fiscal 2024.
1.29
0.10
−7.19%
Follow ZCMD
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 3 | 4 | 2 | 6 | 5 | 3 |
P/E ratio |
25.00 | 25.00 | 25.00 | 74,400.00 | 139,402.11 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | 18.95 | 16.08 | 7.26 | 2.62 | 6.77 | 9.11 |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | 10.75 | 13.19 | 17.78 | 14.11 | 9.18 | 6.22 | 17.89 | 15.87 |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | (0.43) | (0.74) | (2.72) | (2.43) | (5.32) | (1.11) | (4.20) |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
0.00 | 0.00 | 0.00 | (0.50) | (0.39) | (0.37) | (0.39) | (0.38) | (0.41) |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.06 | 1.81 | 1.76 | 1.88 |
EV/Operating CF |
0.00 | 0.00 | 0.00 | 4.97 | (12.66) | (3.75) | 3.90 | 5.02 | (6.59) |
EV/FCF |
0.00 | 0.00 | 0.00 | 2.94 | 4.63 | 9.54 | 2.76 | 1.47 | 3.22 |
Quick Ratio |
3.90 | 4.75 | 5.48 | 9.20 | 6.64 | 4.57 | 5.97 | 11.61 | 10.94 |
Current Ratio |
4.10 | 5.38 | 6.15 | 9.92 | 7.59 | 5.45 | 6.99 | 12.22 | 11.11 |
Net Debt/EBITDA |
(4.51) | (2.52) | (2.09) | (3.65) | (679.96) | 4.68 | 1.05 | 118.73 | 2.36 |
Debt/Assets |
0.00% | 5.18% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.93 | 1.83 | 0.94 | 0.68 | 0.46 | 0.38 | 0.62 | 0.63 | 0.45 |
Operating CF/Net income |
(0.35) | 0.43 | 0.35 | (0.23) | 11.99 | 0.23 | 0.00 | 2.29 | (0.13) |
Capex/Depreciation |
0.00 | (28.08) | (12.76) | (0.79) | (5.27) | (1.31) | (1.56) | (13.18) | (0.53) |
Interest Coverage |
121.23 | — | — | — | — | — | — | — | — |
| 18.40% | 36.39% | 30.29% | 18.90% | 0.74% | (8.97%) | (41.94%) | (2.85%) | (27.00%) | |
| 14.55% | 42.99% | 25.46% | 16.97% | 0.67% | (7.85%) | (35.97%) | (2.56%) | (25.22%) | |
ROIC |
0.00% | 67.54% | 30.33% | 19.05% | (1.09%) | (8.80%) | (109.36%) | (1.93%) | (44.60%) |
Return on Tangible Assets |
31.21% | 27.71% | 28.82% | 15.58% | 0.87% | (13.11%) | (58.87%) | (2.79%) | (29.61%) |
Average Days of Receivables |
48.40 | 56.55 | 124.90 | 209.42 | 215.26 | 180.53 | 47.94 | 107.73 | 89.29 |
Research and Development Expense of Revenue |
9.61% | 11.25% | 5.81% | 4.54% | 4.66% | 2.91% | 2.65% | 1.59% | 0.07% |
Selling, General and Administrative Expense of Revenue |
39.27% | 28.66% | 38.44% | 36.50% | 55.23% | 62.89% | 68.99% | 56.74% | 99.38% |
Intangible Assets out of Total Assets |
0.00 | 0.03 | 0.02 | 0.00 | 0.01 | 0.17 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | (0.11%) | 1.08% | 0.94% | 1.30% | 1.14% | 0.70% | 0.69% | 32.57% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
4.00% | 4.00% | 4.00% | 0.00% | 0.00% | 0.00% | (0.01%) | (0.01%) | (0.05%) |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.39 | 4,594.96 | 5,132.00 | 5,451.45 | 4,793.18 | 4,043.29 | 5,552.54 | 2,266.40 | 309.10 |
Operating CF per Share |
(0.02) | 468.79 | 485.52 | (314.48) | 841.71 | (189.06) | 15.49 | (210.46) | 22.97 |
Capex per Share |
0.00 | (388.07) | (452.72) | (48.67) | (529.38) | (143.86) | (230.89) | (435.03) | (4.15) |
Free Cash Flow per Share |
(0.02) | 80.71 | 32.79 | (363.15) | 312.32 | (332.91) | (215.40) | (645.49) | 18.83 |
Cash per Share |
0.19 | 3,243.64 | 2,700.90 | 5,183.61 | 4,179.74 | 3,439.69 | 3,841.86 | 1,869.11 | 378.33 |
Shareholders Equity per Share |
0.21 | 4,066.21 | 5,289.14 | 9,646.70 | 9,578.35 | 9,434.09 | 6,010.91 | 3,450.16 | 614.08 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.21 | 4,066.21 | 5,289.14 | 9,646.70 | 9,578.35 | 9,434.09 | 6,010.91 | 3,450.16 | 614.08 |
Free Cash Flow |
(0.54) | 0.23 | 0.10 | (1.20) | 1.06 | (1.17) | (0.75) | (4.52) | 0.69 |
Working Capital |
4.85 | 10.23 | 12.15 | 26.61 | 23.67 | 18.54 | 16.03 | 17.18 | 15.44 |
Capital Expenditures |
(0.08) | (1.09) | (1.31) | (0.16) | (1.80) | (0.50) | (0.81) | (3.05) | (0.15) |
Net Current Asset Value |
4.85 | 9.90 | 12.11 | 26.61 | 23.55 | 17.11 | 15.33 | 16.97 | 15.41 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.08 | 0.09 | 0.01 | 0.11 | 0.04 | 0.04 | 0.19 | 0.01 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.31 | 0.06 | 0.05 | 0.10 | 0.09 | 0.10 | 0.16 | 0.04 | 0.05 |
Cash ROIC |
(5.37%) | 1.07% | 0.41% | (2.45%) | 2.27% | (2.59%) | (2.19%) | (12.13%) | 1.90% |
Accounts Receivable Turnover |
5.96 | 7.81 | 4.20 | 2.33 | 1.64 | 1.70 | 4.07 | 4.39 | 3.05 |
Accounts Payable Turnover |
13.11 | 14.71 | 66.18 | 23.28 | 30.66 | 86.75 | 26.49 | 11.41 | 11.79 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 27.95 | 11.80 | 0.00 |
Average Days of Payables |
53.52 | 1.93 | 9.18 | 24.37 | 2.07 | 6.59 | 22.86 | 28.09 | 30.71 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.85 | 19.80 | 30.77 | 0.00 |
Average Receivables |
1.65 | 1.65 | 3.54 | 7.71 | 9.97 | 8.31 | 4.78 | 3.62 | 3.73 |
Average Payables |
0.30 | 0.30 | 0.07 | 0.26 | 0.22 | 0.09 | 0.41 | 0.61 | 0.53 |
Average Inventory |
— | — | — | — | — | — | 0.39 | 0.59 | — |
Average Assets |
10.51 | 7.02 | 15.89 | 26.28 | 35.54 | 37.44 | 31.52 | 25.15 | 25.02 |
Average Common Equity |
8.31 | 8.30 | 13.36 | 23.59 | 32.20 | 32.79 | 27.03 | 22.59 | 23.37 |
Columns are period end dates